Cargando…

Survival in patients with HR+/HER2− metastatic breast cancer treated with initial endocrine therapy versus initial chemotherapy. A French population-based study

BACKGROUND: According to international guidelines, endocrine therapy (ET) is the preferred option for hormone receptor-positive (HR+) HER2-negative (HER2−) metastatic breast cancer. In spite of clear recommendations, these are not strictly followed in daily practice. The objectives of this study wer...

Descripción completa

Detalles Bibliográficos
Autores principales:	Simon, Julien, Chaix, Marie, Billa, Oumar, Kamga, Ariane Mamguem, Roignot, Patrick, Ladoire, Sylvain, Coutant, Charles, Arveux, Patrick, Quantin, Catherine, Dabakuyo-Yonli, Tienhan Sandrine
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7525445/ https://www.ncbi.nlm.nih.gov/pubmed/32678278 http://dx.doi.org/10.1038/s41416-020-0979-3

Ejemplares similares

Trends in endocrine therapy prescription and survival in patients with non-metastatic hormone receptor positive breast cancer treated with endocrine therapy: A population based-study
por: Mamguem Kamga, Ariane, et al.
Publicado: (2021)

Impact of routine assessment of health-related quality of life coupled with therapeutic information on compliance with endocrine therapy in patients with non-metastatic breast cancer: protocol for a randomized controlled trial
por: Mamguem Kamga, Ariane, et al.
Publicado: (2020)

What Are Young Women Living Conditions after Breast Cancer? Health-Related Quality of Life, Sexual and Fertility Issues, Professional Reinsertion
por: Assogba, Emerline L. F., et al.
Publicado: (2020)

Long-term quality of life and sexual function of elderly people with endometrial or ovarian cancer
por: Mamguem Kamga, Ariane, et al.
Publicado: (2021)

Breast cancer subtype of French women is not influenced by socioeconomic status: A population-based-study
por: Auguste, Aviane, et al.
Publicado: (2017)

Impact of Covid-19 on breast cancer stage at discovery, and time to treatment in Cote d’Or, France
por: Feron Agbo, Clémence, et al.
Publicado: (2023)

Effect of Obesity among Hospitalized Cancer Patients with or without COVID-19 on a National Level
por: Cottenet, Jonathan, et al.
Publicado: (2022)

Quality of life and perceived burden of the primary caregiver of patients aged 70 and over with cancer 5 years after initial treatment
por: Barben, Jérémy, et al.
Publicado: (2023)

Population-based study of breast cancer in older women: prognostic factors of relative survival and predictors of treatment
por: Dialla, Pegdwende Olivia, et al.
Publicado: (2012)

COVID-19 epidemiological, sociological and anthropological investigation: study protocol for a multidisciplinary mixed methods research in Burkina Faso
por: Traoré, Isidore Tiandiogo, et al.
Publicado: (2021)

Cross-sectional nationwide mixed-methods population-based study of living conditions, and identification of sexual and fertility profiles among young women after breast cancer in France: the Candy study protocol
por: Assogba, Emerline L F, et al.
Publicado: (2022)

Prognosis of local invasive relapses after carcinoma in situ of the breast: a retrospective study from a population-based registry
por: Kada Mohammed, Samia, et al.
Publicado: (2022)

Population-based study of ovarian cancer in Côte d'Or: prognostic factors and trends in relative survival rates over the last 20 years
por: Hamidou, Zeinab, et al.
Publicado: (2010)

Incidence rate and predictors of COVID-19 in the two largest cities of Burkina Faso - prospective cohort study in 2021 (ANRS-COV13)
por: Kaboré, Nongodo Firmin, et al.
Publicado: (2023)

The burden of the coronavirus disease 2019 virus infection in Burkina Faso: Results from a World Health Organization UNITY population‐based, age‐stratified sero‐epidemiological investigation
por: Ouedraogo, Samiratou, et al.
Publicado: (2023)

For patients with breast cancer, geographic and social disparities are independent determinants of access to specialized surgeons. A eleven-year population-based multilevel analysis
por: Gentil, Julie, et al.
Publicado: (2012)

Impact of therapeutic strategy on disease‐free and overall survival of early‐stage cervical cancer: Surgery alone versus preoperative radiation
por: Mahiou, Katia, et al.
Publicado: (2023)

Randomized Trial Assessing the Impact of Routine Assessment of Health-Related Quality of Life in Patients with Head and Neck Cancer
por: Billa, Oumar, et al.
Publicado: (2021)

PB2697: LONG TERM PEJORATIVE IMPACT OF LENALIDOMIDE MAINTENANCE ON HEALTH-RELATED QUALITY OF LIFE IN CHRONIC LYMPHOCYTIC LEUKEMIA. ANCILLARY STUDY OF THE PHASE III CLL6-RESIDUUM TRIAL
por: Wasse, Stephane, et al.
Publicado: (2023)

Trends in molecular subtypes of breast cancer: description of incidence rates between 2007 and 2012 from three French registries
por: Cortet, Marion, et al.
Publicado: (2018)

Quality of Life and Needs in Caregivers: Results From the Prospective Multicentric Open-Label Randomized Study of Informal Caregivers of Elderly Patients
por: Pozet, Astrid, et al.
Publicado: (2023)

P1746: LONG-TERM NON-HODGKIN LYMPHOMA SURVIVORS IN CÔTE D’OR: HEALTH-RELATED QUALITY OF LIFE AND LIVING CONDITIONS.
por: Wasse, S., et al.
Publicado: (2022)

Factors Affecting Health-Related Quality of Life among Survivors of Non-Hodgkin Lymphoma: A Population-Based Study
por: Wasse, Stephane Kroudia, et al.
Publicado: (2023)

Is Gestational Diabetes Mellitus a Risk Factor of Maternal Breast Cancer? A Systematic Review of the Literature
por: Simon, Julien, et al.
Publicado: (2021)

Real-world patient-reported outcomes of women receiving initial endocrine-based therapy for HR+/HER2− advanced breast cancer in five European countries
por: Davie, Alison, et al.
Publicado: (2020)

Impact de COVID-19 sur le stade du cancer du sein à la découverte et le délai de traitement en Côte d'Or, France
por: Feron Agbo, C., et al.
Publicado: (2023)

Enrolling study personnel in Ebola vaccine trials: from guidelines to practice in a non-epidemic context
por: Lhomme, Edouard, et al.
Publicado: (2019)

Increased Risk of Hospitalization for Pancreatic Cancer in the First 8 Years after a Gestational Diabetes Mellitus regardless of Subsequent Type 2 Diabetes: A Nationwide Population-Based Study
por: Simon, Julien, et al.
Publicado: (2021)

Impact of Response Shift on Time to Deterioration in Quality of Life Scores in Breast Cancer Patients
por: Hamidou, Zeinab, et al.
Publicado: (2014)

Impact of sentinel node biopsy on long-term quality of life in breast cancer patients
por: De Gournay, E, et al.
Publicado: (2013)

Long-term Pooled Safety Analysis of Palbociclib in Combination With Endocrine Therapy for HR+/HER2- Advanced Breast Cancer
por: Diéras, Véronique, et al.
Publicado: (2018)

Cost-effectiveness of ribociclib plus endocrine therapy versus placebo plus endocrine therapy in HR-positive, HER2-negative breast cancer
por: Le, Vivian, et al.
Publicado: (2021)

Endocrine Symptoms as the Initial Manifestation of Wilson’s Disease
por: Krysiak, Robert, et al.
Publicado: (2012)

Clinical Outcomes with First-line Endocrine Therapy or Chemotherapy in Postmenopausal HR+/HER2− Metastatic Breast Cancer
por: Song, Yan, et al.
Publicado: (2015)

Real life efficacy of palbociclib and endocrine therapy in HR positive, HER2 negative advanced breast cancer
por: Porte, B., et al.
Publicado: (2020)

French Endocrine Society Guidance on endocrine side effects of immunotherapy
por: Castinetti, F, et al.
Publicado: (2018)

Real-world effectiveness and sensitivity of palbociclib plus endocrine therapy in HR+/HER2– patients with metastatic breast cancer
por: Li, Jingping, et al.
Publicado: (2021)

Cost-effectiveness of abemaciclib plus endocrine therapy in high-risk HR+/HER2–early breast cancer in China
por: Wei, Qiran, et al.
Publicado: (2023)

Zebrafish model of KRAS-initiated pancreatic endocrine tumor
por: Oh, Sekyung, et al.
Publicado: (2019)

Comparison of Cancer Patients to Non-Cancer Patients among COVID-19 Inpatients at a National Level
por: Bernard, Alain, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_d62inhk18qepgjd2pkhjs8vnso